BBA

Baker Bros. Advisors Portfolio holdings

AUM $13.8B
1-Year Est. Return 85.12%
This Quarter Est. Return
1 Year Est. Return
+85.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.79B
AUM Growth
-$8.56B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1
+$159M
2
+$98.3M
3
+$70.5M
4
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$67.8M
5
REPL icon
Replimune Group
REPL
+$41.9M

Top Sells

1
+$9.45B
2
+$337M
3
+$198M
4
SWTX
SpringWorks Therapeutics
SWTX
+$69.4M
5
ROIV icon
Roivant Sciences
ROIV
+$48.1M

Sector Composition

1 Healthcare 98.37%
2 Financials 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$8.16M 0.09%
2,000,000
52
$7.89M 0.09%
1,456,518
+641,159
53
$7.8M 0.09%
535,478
54
$7.66M 0.09%
315,381
55
$7.64M 0.09%
2,588,645
-102,246
56
$7.42M 0.08%
750,000
57
$7.09M 0.08%
4,004,756
+1,500,000
58
$6.58M 0.07%
812,815
+6,275
59
$5.62M 0.06%
190,476
60
$5.21M 0.06%
245,431
+122,304
61
$4.86M 0.06%
1,172,175
62
$3.98M 0.05%
1,500,000
63
$3.79M 0.04%
508,323
64
$3.07M 0.03%
763,970
65
$3.07M 0.03%
48,885
66
$2.93M 0.03%
131,533
+6,205
67
$2.65M 0.03%
797,460
-351,880
68
$2.52M 0.03%
43,445
69
$2.43M 0.03%
1,557,630
70
$1.87M 0.02%
2,102,792
-454,357
71
$1.87M 0.02%
266,613
72
$1.38M 0.02%
83,056
73
$1.11M 0.01%
1,764,546
74
$1.01M 0.01%
+35,000
75
$998K 0.01%
322,024
1 2
3
4 5